BusinessMidatech Pharma PLC (“Midatech” or the “Company”) Audited financial results for the year ended 31 December 2015By Nasdaq OMXApr 13, 2016, 6:00 AM UTC
BusinessMidatech’s Commercial Launch of Zuplenz® (Ondansetron) Oral Soluble Film to Prevent Post-Operative, Chemotherapy and Radiation-Induced Nausea and Vomiting in USBy Nasdaq OMXApr 11, 2016, 6:00 AM UTC
